SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Syndax management to participate in September investor conferences

Syndax Pharmaceuticals said CEO Michael A. Metzger and members of the management team will participate in September investor conferences.

SNDX

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories